TAP Biosystems and Merck & Co., Inc. Double Triumph at BPI 2014 Awards

At the BioProcess International Awards, TAP Biosystems and Merck won the ‘Best

Collaboration Award'' beating off stiff competition from other partnerships including

Invetech and Janssen. TAP Biosystems and Merck also won the ‘Best Technology Application

— Upstream Award'' for the ambr250 automated mini bioreactor system against other excellent products such as the Xcellerex™ XDR-50 MO fermenter system and the MaxCyte®

STX™ Scalable Transfection System.

Mwai Ngibuini, ambr250 Product Manager stated: “The main aim of our collaboration with Merck was to develop a simple to set up, single-use mini bioreactor system which has the versatility to replicate traditional bioreactors and fermenters for culturing mammalian and microbial cells. To achieve this we listened carefully to the bioprocessing experts that would use the system, as well as the context into which it would be placed and then worked tirelessly to deliver their vision.”

Ngibuini continued: “We''re delighted to win these awards with Merck because it indicates that the time and effort we all put into this partnership has really been worthwhile and the ambr250 is viewed by our bioprocess peers and experts as breakthrough technology, which has the potential to totally transform process development of antibody and protein-basedtherapeutics.”

A profile of Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and

produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.”

Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 3,300 people, and in 2013 earned sales revenue of 588.4 million euros.

TAP Biosystems, part of the Sartorius Stedim Biotech Group, is a leading global provider of automated cell culture and fermentation systems for life science research, development and production. TAP''s systems are in use worldwide at pharmaceutical, biotechnology and academic laboratories, supporting

bioprocess development and GMP manufacture of biologics and cell therapies, as well as discovery and stem cell research programmes.

About BioProcess International Award

The awards celebrate the outstanding achievements, collaborations, business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base. Organized by BioProcess International (BPI) is a business-tobusiness publication dedicated to delivering cutting-edge information focused on the development and

manufacture of biopharmaceuticals and therapeutics. Learn more at http://www.bioprocessintl.com.